Skip to main content
Clinical Trials/NCT05557084
NCT05557084CompletedNot Applicable

Laparoscopic Clip-Gastroplasty With The Use Of Bariclip

University of Rome Tor Vergata2 sites in 1 country50 target enrollmentStarted: July 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
50
Locations
2
Primary Endpoint
% Excess Weight Loss

Study Overview

Brief Summary

Sleeve gastrectomy, the most commonly performed bariatric surgery procedure, carries limitations both short-term including postoperative complications such as hemorrhage and gastric fistula and long-term such as weight regain and gastro-esophageal reflux. A new procedure has been proposed to overcome many of these limitations: laparoscopic vertical clip gastroplasty (LVCG) with Bariclip. Primary outcome were major postoperative complications. Secondary outcomes included weight loss, incidence of de-novo GERD and comorbidity resolution.

Detailed Description

Methods. The investigators performed a review of data from a prospectively collected database. All patients submitted to primary LVCG were examined. Patients were submitted to LVCG Between July 2021 and March 2022. Collected data included demographic factors, pre-operative weight, pre-operative BMI, operative time, surgical complications, and clinical outcomes in terms of short and mid-term weight loss.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • BMI > 40 BMI > 35 and comorbidities BMI > 30 with poorly controlled Diabetes mellitus II or hypertension

Exclusion Criteria

  • Alcoholism Drug addiction Psychiatric Disease

Outcomes

Primary Outcomes

% Excess Weight Loss

Time Frame: 1 year

Weight loss after laparoscopic vertical clip gastroplasty during the follow-up

Secondary Outcomes

  • Post-operative complications(1 year)

Investigators

Sponsor
University of Rome Tor Vergata
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Paolo Gentileschi

Head of Department of Bariatric and Metabolic Surgery

University of Rome Tor Vergata

Study Sites (2)

Loading locations...

Similar Trials